6-Bromo-betamethasone 17,21-Dipropionate
CAS: 1186048-34-9
Ref. TR-B680330
| 10mg | 116.00 € | ||
| 25mg | 170.00 € | ||
| 100mg | 503.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Product Information
Name:
6-Bromo-betamethasone 17,21-Dipropionate
Controlled Product
Synonyms:
- (11ß,16ß)-6-Bromo-9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione
- 6-Bromobetamethasone Dipropionate
- (11β,16β)-6-Bromo-9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,20-dione
- Pregna-1,4-diene-3,20-dione, 6-bromo-9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β)-
- 6-Bromobetamethasone dipropionate
Description:
Stability Hygroscopic
Applications 6-Bromo-Betamethasone 17,21-Dipropionate (Betamethasone Dipropionate EP Impurity H) is an impurity of Betamethasone (B327000), a glucocorticoid used as an anti-inflammatory agent.
References Ferrante, M.G., et al.: Anal. Profiles Drug Subs., 6, 43 (1977); Li, A., et al.: Chem. Biol. Interact., 142, 7 (2002); Cruz-Monteagudo, M., et al.: Eur. J. Med. Chem., 40, 1030 (2005)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
583.48
Formula:
C28H36BrFO7
Color/Form:
Neat
InChI:
InChI=1S/C28H36BrFO7/c1-6-23(34)36-14-22(33)28(37-24(35)7-2)15(3)10-17-18-12-20(29)19-11-16(31)8-9-25(19,4)27(18,30)21(32)13-26(17,28)5/h8-9,11,15,17-18,20-21,32H,6-7,10,12-14H2,1-5H3/t15-,17-,18-,20?,21-,25-,26-,27-,28-/m0/s1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-B680330 6-Bromo-betamethasone 17,21-Dipropionate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
